Toggle light / dark theme

Click here to read the full article.

The Hyperloop may still be a decade from becoming a reality, but already people are trying to improve upon the concept. Chinese architecture firm MAD is developing an eco-friendly version of the futuristic transportation system, one that would utilize solar and wind energies to operate.

Earlier this week, MAD announced that it was working with US-based Hyperloop Transportation Technologies on a new sustainable design with the aim of creating “enhanced connectivity between cities and people,” according to CNN. The proposed Hyperloop draws its power from a system of solar panels and wind turbine forests.

Lab chemists and computer scientists are joining forces to find a nerve-agent antidote that will go where today €™s antidotes can €™t go €“ the brain. Read more about in the latest issue of our Science & Technology Review magazine †’ https://str.llnl.gov/2019-06/valdez

This invention relates to a spacecraft propulsion system utilizing thrusters comprised of a motor-driven electrostatically charged cylinder rotating within an electrostatically charged annular ring for the purpose of creating a spacetime curvature stress-energy tension in the horizontal direction. The thrusters are augmented by magnetic vortex generators, either embedded in the cylinders or located above each thruster, for the purpose of increasing the permittivity of space by permeating each thruster with low density hyperspace energy generated by a wormhole created between our space and hyperspace. A combination of three thrusters mounted on the underside of the hull of the spacecraft provide thrust and yaw motion control.

The replacement of animals as test subjects is one step closer to reality with the successful testing of multi-organ “human-on-a-chip” models to recapitulate the 28-day experiments typically used in animals to evaluate the systemic toxicity of drug and cosmetic compounds. As published and featured as a frontispiece in the prestigious peer-reviewed scientific journal Advanced Functional Materials, the microfluidic device with interlinking modules containing human-derived heart, liver, skeletal muscle and nervous system cells was able to maintain cellular viability and record cellular function in real-time for 28 days.

The University of Central Florida (UCF) in collaboration with the Florida biotech firm Hesperos, Inc., has shown that one of its innovative four-organ in vitro (out of body) model systems is able to realistically replicate in vivo (in body) responses to sustained drug dosing of human cells.

“The technology could allow us, in the very near future, to move chronic drug experiments from animal models to these novel human in vitro models,” said Hesperos Chief Scientist James J. Hickman, who is a Professor at UCF’s NanoScience Technology Center.